Search Results - "Fratta, E."

Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models by Covre, A, Coral, S, Nicolay, H, Parisi, G, Fazio, C, Colizzi, F, Fratta, E, Di Giacomo, A M, Sigalotti, L, Natali, P G, Maio, M

“…The multifaceted immunomodulatory activity of DNA hypomethylating agents improves immunogenicity and immune recognition of neoplastic cells; thus, we predicted…”
Get full text

Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success? by Sigalotti, L, Fratta, E, Parisi, G, Coral, S, Maio, M

Get full text

Predictive Value of CD8 Expression and FoxP3 Methylation in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy in a Non-endemic Area by Muraro, E., Vaccher, E., Furlan, C., Fratta, E., Fanetti, G., Fae’, D. A., Martorelli, D., Cangemi, M., Polesel, J., Navarria, F., Gobitti, C., Comaro, E., Scaini, C., Pratesi, C., Zanussi, S., Lupato, V., Grando, G., Giacomarra, V., Sulfaro, S., Barzan, L., Dolcetti, R., Steffan, A., Canzonieri, V., Franchin, G.

“…Undifferentiated Nasopharyngeal Carcinoma (UNPC) is associated with Epstein-Barr Virus (EBV) and characterized by an abundant immune infiltrate potentially…”
Get full text

Role of non-coding RNAs in resistance to targeted therapies in cutaneous melanoma by Montico, B, Giurato, G, Polano, M, Rizzo, A, Dal Col, J, Ravo, M, Weisz, A, Dolcetti, R, Colizzi, F, Sigalotti, L, Fratta, E

“…An abstract of the study of Montico et al about the role of non-coding RNAs in resistance to targeted therapies in cutaneous melanoma is presented. Among other…”
Get full text

Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications by Coral, S, Covre, A, JMG Nicolay, H, Parisi, G, Rizzo, A, Colizzi, F, Dalla Santa, S, Fonsatti, E, Fratta, E, Sigalotti, L, Maio, M

“…Background: Epigenetic remodelling of cancer cells is an attractive therapeutic strategy and distinct DNA hypomethylating agents (DHA) are being actively…”
Get full text

V.01.12 OVER-THE-SCOPE CLIP-ASSISTED ENDOSCOPIC FULL THICKNESS RESECTION AFTER INCOMPLETE RESECTION OF RECTAL ADENOCARCINOMA: CASE AND VIDEO REPORT by Soriani, P, Tontini, G.E, Pastorelli, L, De Nucci, G, Steffano, G.B, Di Fratta, E, Vecchi, M, Lagoussis, P

Get full text

OC.12.9: Endoscopic Full-Thickness Resection for T1 Early Rectal Cancer: A Pilot Study (with Videos) by Soriani, P, Tontini, G.E, Neumann, H, De Nucci, G, De Toma, D, Bruni, B, Di Fratta, E, Vavassori, S, Pastorelli, L, Vecchi, M, Lagoussis, P

Get full text

468 Prognostic Potential of Integrated Whole Genome Methylation and Expression Profiling in Cutaneous Melanoma by Sigalotti, L, Fratta, E, Parisi, G, Covre, A, Sonego, P, Rizzo, A, Colizzi, F, Coral, S, Massarut, S, Maio, M

Get full text

547 Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidinecontaining demethylating dinucleotide by Coral, S, Sigalotti, L, Parisi, G, Colizzi, F, Fratta, E, Nicolay, H.J.M, Taverna, P, Maio, M

Get full text

281 (PB269): Emerging role of HOXB9 transcription factor in cutaneous melanoma by Montico, B., Bellazzo, A., Salvati, A., Guerrieri, R., Colizzi, F., Nassa, G., Lamberti, J., Weisz, A., Covre, A., Maio, M., Steffan, A., Fratta, E.

Get full text

271 (PB259): Spry1 silencing reduces HIF1α-induced glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma by Montico, B., Giurato, G., Guerrieri, R., Colizzi, F., Salvati, A., Nassa, G., Lamberti, J., Sabatelli, P., Comelli, M., Bellazzo, A., Camicia, L., Baboci, L., Nyman, T., Weisz, A., Steffan, A., Sigalotti, L., Mongiat, M., Andreuzzi, E., Fratta, E.

Get full text

PO-0802: Impact of LINE-1 methylation on survival in patients with locally advanced oropharyngeal carcinoma by Fanetti, G., Lupato, V., Casarotto, M.T., Sulfaro, S., Giacomarra, V., Furlan, C., Baggio, V., Romeo, S., Boscolo-Rizzo, P., Vaccher, E., Franchin, G., Polesel, J., Fratta, E.

Get full text

PO-0965 Vitamin D, vitamin B12 and acute toxicity in head and neck cancer patients undergoing radiotherapy by Fanetti, G., Polesel, J., Matrone, F., Turturici, I., Gobitti, C., Alfieri, S., Lupato, V., La Torre, F.B., Fratta, E., Muraro, E., Casarotto, M.T., Guerrieri, R., Giacomarra, V., Steffan, A., Vaccher, E., Franchin, G.

Get full text

Prognostic Significance of Immune Microenvironmental Factors in Undifferentiated Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy by Muraro, E., Vaccher, E., Furlan, C., Fratta, E., Fae', D.A., Martorelli, D., Polesel, J., Fanetti, G., Farina, E., Navarria, F., Comaro, E., Lupato, V., Giacomarra, V., Sulfaro, S., Barzan, L., Grando, G., Dolcetti, R., Steffan, A., Canzonieri, V., Franchin, G.

Get full text

216 - Role of non-coding RNAs in resistance to targeted therapies in cutaneous melanoma by Montico, B., Giurato, G., Polano, M., Rizzo, A., Dal Col, J., Ravo, M., Weisz, A., Dolcetti, R., Colizzi, F., Sigalotti, L., Fratta, E.

Get full text

Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine by SIGALOTTI, Luca, FRATTA, Elisabetta, CORAL, Sandra, TANZARELLA, Silvia, DANIELLI, Riccardo, COLIZZI, Francesca, FONSATTI, Ester, TRAVERSARI, Catia, ALTOMONTE, Maresa, MAIO, Michele

“…Cancer/testis antigens (CTA) are suitable targets for immunotherapy of human malignancies, and clinical trials are mainly focusing on MAGE-A3. However, the…”
Get full text

Immunomodulatory Activity of SGI-110, a Second Generation Hypomethylating Agent by Maio, M., Choy, G., Covre, A., Parisi, G., Nicolay, H., Fratta, E., Fonsatti, E., Sigalotti, L., Coral, S., Taverna, P., Azab, M.

Get full text

Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications by Coral, Sandra, Sigalotti, Luca, Colizzi, Francesca, Spessotto, Alberto, Nardi, Gianpaolo, Cortini, Enzo, Pezzani, Laura, Fratta, Elisabetta, Fonsatti, Ester, Di Giacomo, Anna Maria, Nicotra, Maria Rita, Natali, Pier Giorgio, Altomonte, Maresa, Maio, Michele

“…Emerging in vitro evidence points to an immunomodulatory activity of DNA hypomethylating drugs in human malignancies. We investigated the potential of…”
Get full text

Epigenetic Modulation of Solid Tumors as a Novel Approach for Cancer Immunotherapy by Sigalotti, Luca, Coral, Sandra, Fratta, Elisabetta, Lamaj, Elda, Danielli, Riccardo, Di Giacomo, Anna Maria, Altomonte, Maresa, Maio, Michele

“…Emerging evidence demonstrates that epigenetic events associated with tumor development and progression may impair immunogenicity and immune recognition of…”
Get full text

Lectures by Chen, D. S., Feltquate, D. M., Smothers, F., Hoos, A., Langermann, S., Marshall, S., May, R., Fleming, M., Hodi, F. S., Senderowicz, A., Wiman, K. G., de Dosso, S., Fiedler, W., Gianni, L., Cresta, S., Schulze-Bergkamen, H. B., Gurrieri, L., Salzberg, M., Dietrich, B., Danielczyk, A., Baumeister, H., Goletz, S., Sessa, C., Strumberg, D., Schultheis, B., Santel, A., Gebhardt, F., Meyer-Sabellek, W., Keil, O., Giese, K., Kaufmann, J., Maio, M., Choy, G., Covre, A., Parisi, G., Nicolay, H., Fratta, E., Fonsatti, E., Sigalotti, L., Coral, S., Taverna, P., Azab, M., Deutsch, E., Lepechoux, C., Pignon, J. P., Tao, Y. T., Rivera, S., Bourgier, B. C., Angokai, M., Bahleda, R., Slimane, K., Angevin, E., Besse, B. B., Soria, J. C., Dragnev, K., Beumer, J. H., Anyang, B., Ma, T., Galimberti, F., Erkmen, C. P., Nugent, W., Rigas, J., Abraham, K., Johnstone, D., Memoli, V., Dmitrovsky, E., Voest, E. E., Siu, L., Janku, F., Tsimberidou, A., Kurzrock, R., Tabernero, J., Rodon, J., Berger, R., Onn, A., Batist, G., Bresson, C., Lazar, V., Molenaar, J. J., Koster, J., Ebus, M., Zwijnenburg, D. A., van Sluis, P., Lamers, F., Schild, L., van der Ploeg, I., Caron, H. N., Versteeg, R., Pouyssegur, J., Marchiq, I., Chiche, J., Roux, D., Le Floch, R., Critchlow, S. E., Wooster, R. F., Agresta, S., Yen, K. E., Janne, P. A., Plummer, E. R., Trinchieri, G.

Get full text